SPDR S&P Biotech ETF (NYSEARCA:XBI) is Means Investment CO. Inc.’s 7th Largest Position


Share on StockTwits

Means Investment CO. Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.0% in the first quarter, Holdings Channel reports. The institutional investor owned 79,729 shares of the exchange traded fund’s stock after buying an additional 784 shares during the quarter. SPDR S&P Biotech ETF comprises about 2.5% of Means Investment CO. Inc.’s portfolio, making the stock its 7th biggest position. Means Investment CO. Inc.’s holdings in SPDR S&P Biotech ETF were worth $10,815,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of XBI. Almanack Investment Partners LLC. lifted its position in SPDR S&P Biotech ETF by 2.7% in the fourth quarter. Almanack Investment Partners LLC. now owns 2,455 shares of the exchange traded fund’s stock valued at $346,000 after purchasing an additional 64 shares during the last quarter. Patten & Patten Inc. TN raised its holdings in shares of SPDR S&P Biotech ETF by 0.8% during the fourth quarter. Patten & Patten Inc. TN now owns 9,990 shares of the exchange traded fund’s stock valued at $1,406,000 after acquiring an additional 75 shares in the last quarter. Pin Oak Investment Advisors Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 56.7% during the fourth quarter. Pin Oak Investment Advisors Inc. now owns 235 shares of the exchange traded fund’s stock valued at $33,000 after acquiring an additional 85 shares in the last quarter. Parallel Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 1.0% during the fourth quarter. Parallel Advisors LLC now owns 9,030 shares of the exchange traded fund’s stock valued at $1,271,000 after acquiring an additional 87 shares in the last quarter. Finally, First Allied Advisory Services Inc. grew its stake in SPDR S&P Biotech ETF by 4.8% in the third quarter. First Allied Advisory Services Inc. now owns 2,237 shares of the exchange traded fund’s stock worth $249,000 after purchasing an additional 102 shares during the period.

XBI stock traded up $1.15 during midday trading on Thursday, hitting $132.90. The stock had a trading volume of 163,279 shares, compared to its average volume of 6,530,088. The business has a 50-day moving average of $143.67 and a two-hundred day moving average of $137.38. SPDR S&P Biotech ETF has a 52-week low of $79.19 and a 52-week high of $174.79.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: What is meant by holder of record?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.